Skip to main content
Log in

Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The present study investigated the protective role of growth hormone (GH) against hyperhomocysteinemia (hHcys)-induced activations of reactive oxygen species/hypoxia-inducible factor (HIF)-1α, epithelial–mesenchymal transition (EMT), and consequent glomerular injury. A hHcys model was induced by folate free diet in mice. The urine protein excretion significantly increased while plasma GH levels dramatically decreased in hHcys. Real-time reverse transcription polymerase chain reaction showed that GH receptor (GHR) level increased in the cortex of hHcys mice, which mainly occurred in podocytes as shown by confocal microscopy. Recombinant mouse growth hormone (rmGH) treatment (0.02 mg/kg, once a day for 6 weeks) significantly restored the plasma GH, inhibited GHR upregulation and attenuated proteinuria. Correspondingly, rmGH treatment also blocked hHcys-induced decrease in the expression of podocin, a podocyte slit diaphragm molecule, and inhibited the increases in the expression of desmin, a podocyte injury marker. It was also demonstrated that in hHcys the expression of epithelial markers, p-cadherin and ZO-1, decreased, while the expression of mesenchymal markers, antifibroblast-specific protein 1 (FSP-1) and α-SMA, increased in podocytes, which together suggest the activation of EMT in podocytes. Nicotinamide adenine dinucleotide phosphate oxidase (Nox)-dependent superoxide anion (O2 .−) and hypoxia-inducible factor-1α (HIF-1α) level in the hHcys mice cortex was markedly enhanced. These hHcys-induced EMT enhancement and Nox-dependent O2 .−/HIF-1α activation were significantly attenuated by rmGH treatment. HIF-1α level increased in Hcys-treated cultured podocytes, which were blocked by rmGH treatment. Meanwhile, homocysteine (Hcys)-induced EMT in cultured podocytes was significantly reversed by HIF-1α siRNA. All these results support the view that GH ameliorates hHcys-induced glomerular injury by reducing Nox-dependent O2 .−/HIF-1α signal pathway and EMT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Arnold RE, Weigent DA (2003) The inhibition of superoxide production in EL4 lymphoma cells overexpressing growth hormone. Immunopharmacol Immunotoxicol 25:159–177

    Article  PubMed  CAS  Google Scholar 

  • Boini KM, Xia M, Li C, Zhang C, Payne LP, Abais JM, Poklis JL, Hylemon PB, Li PL (2011a) Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice. Am J Pathol 179(5):2210–2219

    Article  PubMed  CAS  Google Scholar 

  • Boini KM, Xia M, Xiong J, Li C, Payne LP, Li PL (2011b) Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis. J Cell Mol Med 6(8):1674–1685

    Google Scholar 

  • Boini KM, Zhang C, Xia M, Poklis JL, Li PL (2010) Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther 334:839–846

    Article  PubMed  CAS  Google Scholar 

  • Chen YF, Li PL, Zou AP (2002) Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation 106:1275–1281

    Article  PubMed  CAS  Google Scholar 

  • Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P, Losonczy G, Pacher P, Austad SN, Bartke A, Ungvari Z (2008) Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol 295:H1882–H1894

    Article  PubMed  CAS  Google Scholar 

  • Deng L, Jiang J, Frank SJ (2012) Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues. Endocrinology 153(5):2311–2322

    Article  PubMed  CAS  Google Scholar 

  • Dressler GR (2006) The cellular basis of kidney development. Annu Rev Cell Dev Biol 22:509–529

    Article  PubMed  CAS  Google Scholar 

  • Erman A, Wabitsch M, Goodyer CG (2011) Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors. Int J Obes (Lond) 35:1520–1529

    Article  CAS  Google Scholar 

  • Feneberg R, Schaefer F, Veldhuis JD (2003) Neuroendocrine adaptations in renal disease. Pediatr Nephrol 18:492–497

    PubMed  Google Scholar 

  • Francis ME, Eggers PW, Hostetter TH, Briggs JP (2004) Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 66:303–312

    Article  PubMed  CAS  Google Scholar 

  • Griguer CE, Oliva CR, Kelley EE, Giles GI, Lancaster JR Jr, Gillespie GY (2006) Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells. Cancer Res 66:2257–2263

    Article  PubMed  CAS  Google Scholar 

  • Haase VH (2009) Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis. Ann N Y Acad Sci 1177:57–65

    Article  PubMed  CAS  Google Scholar 

  • Hedayati N, Annambhotla S, Jiang J, Wang X, Chai H, Lin PH, Yao Q, Chen C (2009) Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg 49:199–207

    Article  PubMed  Google Scholar 

  • Iacobini C, Menini S, Oddi G, Ricci C, Amadio L, Pricci F, Olivieri A, Sorcini M, Di Mario U, Pesce C, Pugliese G (2004) Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. FASEB J 18:1773–1775

    PubMed  CAS  Google Scholar 

  • Kang YS, Li Y, Dai C, Kiss LP, Wu C, Liu Y (2010) Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 78:363–373

    Article  PubMed  CAS  Google Scholar 

  • Krieg RJ Jr, Veldhuis JD, Thornhill BA, Chevalier RL, Gil G (2008) Growth hormone (GH) secretion, GH-dependent gene expression, and sexually dimorphic body growth in young rats with chronic renal failure. Endocrine 33:323–330

    Article  PubMed  CAS  Google Scholar 

  • Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R (2010) Targeting podocyte-associated diseases. Adv Drug Deliv Rev 62:1325–1336

    Article  PubMed  CAS  Google Scholar 

  • Lewandowski KC, Murray RD, Drzewoski J, O'Callaghan CJ, Czupryniak L, Hillhouse EW, Shalet SM, Randeva HS (2003) Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement. Mol Genet Metab 80:330–337

    Article  PubMed  CAS  Google Scholar 

  • Li CX, Xia M, Han WQ, Li XX, Zhang C, Boini KM, Liu XC, Li PL (2011) Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes. Cell Physiol Biochem 27:691–702

    Article  PubMed  CAS  Google Scholar 

  • Li N, Yi F, Sundy CM, Chen L, Hilliker ML, Donley DK, Muldoon DB, Li PL (2007) Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. Am J Physiol Renal Physiol 292:F207–F216

    Article  PubMed  CAS  Google Scholar 

  • Liu Y (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21:212–222

    Article  PubMed  CAS  Google Scholar 

  • Mak RH, Cheung WW, Roberts CT Jr (2008) The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res 18:17–25

    Article  PubMed  CAS  Google Scholar 

  • Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, Zhang H, Tyagi SC (2006) Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291:H2825–H2835

    Article  PubMed  CAS  Google Scholar 

  • Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17:17–25

    Article  PubMed  CAS  Google Scholar 

  • Nangaku M, Fujita T (2008) Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertens Res 31:175–184

    Article  PubMed  Google Scholar 

  • Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN (1999) Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84:453–457

    Article  PubMed  CAS  Google Scholar 

  • Rabkin R, Awwad I, Chen Y, Ashley EA, Sun D, Sood S, Clusin W, Heidenreich P, Piecha G, Gross ML (2008) Low-dose growth hormone is cardioprotective in uremia. J Am Soc Nephrol 19:1774–1783

    Article  PubMed  CAS  Google Scholar 

  • Randeva HS (2003) Hormonal regulation of homocysteine. Metab Syndr Relat Disord 1:121–128

    Article  PubMed  CAS  Google Scholar 

  • Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82:636–643

    PubMed  CAS  Google Scholar 

  • Sabanayagam C, Shankar A (2010) Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease. Clin Exp Nephrol 15(1):92–99

    Article  PubMed  Google Scholar 

  • Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293:1082–1088

    Article  PubMed  CAS  Google Scholar 

  • Seiva FR, Ebaid GM, Castro AV, Okoshi K, Nascimento A, Rocha KK, Padovani CR, Cicogna AC, Novelli EL (2008) Growth hormone and heart failure: oxidative stress and energetic metabolism in rats. Growth Horm IGF Res 18:275–283

    Article  PubMed  CAS  Google Scholar 

  • Sen U, Basu P, Abe OA, Givvimani S, Tyagi N, Metreveli N, Shah KS, Passmore JC, Tyagi SC (2009) Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol 297:F410–F419

    Article  PubMed  CAS  Google Scholar 

  • Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A (2001) Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab 86:1518–1524

    Article  PubMed  CAS  Google Scholar 

  • Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S, Liu L, Du R, Xia L, He L, Fan D (2009) Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 75:1278–1287

    Article  PubMed  CAS  Google Scholar 

  • Triantafyllou N, Evangelopoulos ME, Kimiskidis VK, Kararizou E, Boufidou F, Fountoulakis KN, Siamouli M, Nikolaou C, Sfagos C, Vlaikidis N, Vassilopoulos D (2008) Increased plasma homocysteine levels in patients with multiple sclerosis and depression. Ann Gen Psychiatry 7:17

    Article  PubMed  Google Scholar 

  • Ungvari Z, Gautam T, Koncz P, Henthorn JC, Pinto JT, Ballabh P, Yan H, Mitschelen M, Farley J, Sonntag WE, Csiszar A (2010) Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats. J Gerontol A Biol Sci Med Sci 65:1145–1156

    Article  PubMed  Google Scholar 

  • Vakili H, Jin Y, Cattini PA (2012) Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells. J Biol Chem 287(40):33282–33292

    Article  PubMed  CAS  Google Scholar 

  • Wang Z, Tang L, Zhu Q, Yi F, Zhang F, Li PL, Li N (2011) Hypoxia-inducible factor-1alpha contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int 79:300–310

    Article  PubMed  CAS  Google Scholar 

  • Wu CH, Tang SC, Wang PH, Lee H, Ko JL (2012) Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem 287:25292–25302

    Article  PubMed  CAS  Google Scholar 

  • Wuhl E, Schaefer F (2002) Effects of growth hormone in patients with chronic renal failure: experience in children and adults. Horm Res 58(Suppl 3):35–38

    PubMed  Google Scholar 

  • Yang MH, Wu KJ (2008) TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 7:2090–2096

    Article  PubMed  CAS  Google Scholar 

  • Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10:295–305

    Article  PubMed  CAS  Google Scholar 

  • Yi F, Jin S, Zhang F, Xia M, Bao JX, Hu J, Poklis JL, Li PL (2009a) Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury. J Cell Mol Med 13:3303–3314

    Article  PubMed  Google Scholar 

  • Yi F, Xia M, Li N, Zhang C, Tang L, Li PL (2009b) Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension 53:90–96

    Article  PubMed  CAS  Google Scholar 

  • Zhang C, Hu JJ, Xia M, Boini KM, Brimson C, Li PL (2010a) Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes. Biochim Biophys Acta 1803:482–491

    Article  PubMed  CAS  Google Scholar 

  • Zhang C, Hu JJ, Xia M, Boini KM, Brimson CA, Laperle LA, Li PL (2010b) Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91(phox) gene. Free Radic Biol Med 48(8):1109–1117

    Article  PubMed  CAS  Google Scholar 

  • Zhang C, Hu JJ, Xia M, Boini KM, Brimson CA, Laperle LA, Li PL (2010c) Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene. Free Radic Biol Med 48:1109–1117

    Article  PubMed  CAS  Google Scholar 

  • Zhang C, Xia M, Boini KM, Li CX, Abais JM, Li XX, Laperle LA, Li PL (2011) Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Pflugers Arch 462:455–467

    Article  PubMed  CAS  Google Scholar 

  • Zhang T, Qu H, Li X, Zhao B, Zhou J, Li Q, Sun M (2010d) Transmembrane delivery and biological effect of human growth hormone via a phage displayed peptide in vivo and in vitro. J Pharm Sci 99:4880–4891

    Article  PubMed  CAS  Google Scholar 

  • Zhu Q, Wang Z, Xia M, Li PL, Van Tassell BW, Abbate A, Dhaduk R, Li N (2011) Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague–Dawley rats. Hypertension 58:657–664

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Institutes of Health [DK54927, HL075316, HL57244].

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Krishna M. Boini or Pin-Lan Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, C., Xia, M., Abais, J.M. et al. Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury. Naunyn-Schmiedeberg's Arch Pharmacol 386, 551–561 (2013). https://doi.org/10.1007/s00210-013-0848-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-013-0848-1

Keywords

Navigation